Allegion Ventures – the corporate venture fund of Allegion plc – has expanded its portfolio with a strategic investment in Asylon, Inc., a leading provider of robotic perimeter security technology. Asylon recently completed a $24 million Series B funding round, which was led by global software investor Insight Partners, with strategic participation from Veteran Ventures Capital and the GO…
Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in AI-powered humanoid robotics, is collaborating with Radium to scale its emotionally intelligent AI applications using Radium’s serverless inference platform to deliver lightning-fast conversations for its next-generation robotic companions. As AI companions become more integrated into everyday technology, emotional responsiveness is emerging as…
Blackstone (NYSE: BX) announced today that private equity funds affiliated with Blackstone (“Blackstone”) have entered into a definitive agreement to acquire Enverus, a premier data analytics energy intelligence platform, from Hellman & Friedman and Genstar Capital. Enverus was founded in 1999 and is a comprehensive data analytics platform empowering its customers’ capital allocation and asset…
A powerhouse team has launched a new initiative called ‘Doing AI Differently,’ which calls for a human-centred approach to future development. For years, we’ve treated AI’s outputs like they’re the results of a giant math problem. But the researchers – from The Alan Turing Institute, the University of Edinburgh, AHRC-UKRI, and the Lloyd’s Register Foundation…
New LIMSConnect system streamlines workflows and supports scalable innovation Sapio Sciences, the science-awareTM lab informatics platform, today announced the full deployment of Sapio LIMS at LabConnect. Internally branded as LIMSConnect, the system now serves as the unified Laboratory Information Management System (LIMS) across LabConnect’s global network of over 30 locations across six continents. LabConnect, a leading provider of…
Digital Wave Technology, provider of the AI-native ONE℠ Platform powered by an AI-native Master Data Management foundation, today announced the appointments of Michael Henne as Chief Financial Officer (CFO) and José Luis Sánchez Castro as Managing Director for Latin America (LATAM). These strategic leadership additions further enhance Digital Wave’s ability to scale globally and deliver cutting-edge solutions…
Accelerate risk reduction, strengthen defensibility, and deliver measurable results with AI-powered vulnerability insights. Liongard, the unified platform driving attack surface management through deep IT visibility and automation, today announced the launch of ThreatImpactIQ, a powerful new addition to the LiongardIQ platform. ThreatImpactIQ empowers IT and security teams to go beyond basic vulnerability scanning by prioritizing risks based…
New risk prioritization and impact analysis solution uniquely combines likelihood and business impact to streamline remediation and reduce cyber risk RedSeal, a pioneer in proactive exposure management, today announced the launch of RedSeal Risk Radius, a next-generation risk prioritization and impact analysis solution designed to help security teams to quickly identify and remediate the exposures…
Company debuts revolutionary innovations that enable end-to-end autonomous security operations, launches DXC Technology strategic partnership, co-presents with customers on security operations transformations 7AI, the leader in agentic security, today unveiled a series of major announcements at Black Hat 2025 that demonstrate the company’s unprecedented momentum in transforming cybersecurity operations through autonomous AI agents. The announcements include…
Exact Sciences acquires exclusive rights to current and future versions of Freenome’s blood-based colorectal cancer screening tests Freenome submitted the final module of the premarket approval application to the FDA for the first-version test Strengthens Exact Sciences’ leadership in colorectal cancer screening by adding blood-based testing to complement Cologuard Exact Sciences Corp. (NASDAQ: EXAS), a…